Apollo Hospitals Enterprise Limited — Investor Meet, 06-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Apollo Hospitals posted robust Q2 FY26 results: consolidated revenue rose 13% to ₹6,303.5 Cr, EBITDA increased 15% to ₹941.2 Cr, and PAT jumped 26% to ₹477.2 Cr. For H1 FY26, consolidated PAT grew 33%. Healthcare Services revenue grew 9% in Q2, while Diagnostics & Retail Health (AHLL) saw 17% growth. Apollo HealthCo's revenue climbed 17%, with PAT quadrupling and cash loss significantly reduced. The company plans to add ~3,600 beds over five years. The HealthCo demerger and listing is targeted for Q4 FY27. Management maintains a positive business outlook.